Expression of the high-risk human papillomavirus (HPV-16) E7 oncoprotein extends the life span of primary human keratinocytes and partially restores telomere length in the absence of telomerase. The molecular basis of this activity is incompletely understood. Here, we show that HPV-16 E7 induces an increased formation of alternative lengthening of telomeres (ALT)-associated promyelocytic leukemia bodies (APBs) in early passage primary human keratinocytes as well as HPV-negative tumor cells. This activity was found to require sequences of HPV-16 E7 involved in degradation of the retinoblastoma tumor suppressor protein as well as regions in the COOH terminus. HPV-16 E7-induced APBs contained ssDNA and several proteins that are involved in the response to DNA replication stress, most notably the Fanconi anemia D2 protein (FANCD2) as well as BRCA2 and MUS81. In line with these results, we found that FANCD2-containing APBs form in an ATR-dependent manner in HPV-16 E7-expressing cells. To directly show a role of FANCD2 in ALT, we provide evidence that knockdown of FANCD2 rapidly causes telomere dysfunction in cells that rely on ALT to maintain telomeres. Taken together, our results suggest a novel link between replication stress and recombination-based telomere maintenance that may play a role in HPV-16 E7-mediated extension of host cell life span and immortalization. [Cancer Res 2008;68(23):9954-63] 
HPV-16 E7 Reveals a Link between DNA Replication Stress, Fanconi Anemia D2 Protein, and Alternative Lengthening of Telomere-Associated Promyelocytic Leukemia Bodies Introduction Unscheduled cell cycle entry is a hallmark of the majority of cancers and inevitably leads to telomere loss followed by antiproliferative responses. The acquisition of mechanisms to bypass these events is a critical step in the evolution of most neoplasms and contributes to the extension of cellular life span and ultimately immortalization. High-risk human papillomaviruses (HPVs) are excellent tools to explore these mechanisms because these tumorigenic viruses encode two oncoproteins, E6 and E7, which have been found to individually extend the life span of primary human cells and to facilitate immortalization when coexpressed (1) (2) (3) .
High-risk HPV types such as HPV-16 are intimately associated with squamous cell carcinomas of the anogenital tract and a subset of oropharyngeal carcinomas. The high-risk HPV-encoded E6 and E7 oncoproteins fulfill critical functions during the viral life cycle (4) . The HPV-16 E7 oncoprotein is a multifunctional protein that binds and degrades the retinoblastoma tumor suppressor protein (pRB) as well as the related proteins p107 and p130 (4) . HPV-16 E7 can also overcome the growth arrest induced by the cyclindependent kinase inhibitors p21
Cip1 and p27 Kip1 and was found to interact with a number of other host cell proteins (4) . The cooperating HPV-16 E6 oncoprotein induces the degradation of the p53 tumor suppressor in addition to several other activities (see below; ref. 4) . Together, the HPV-associated oncoproteins profoundly disrupt the G 1 -S cell cycle checkpoint control thus creating an S phase-like milieu in terminally arrested host keratinocytes that is required for viral genome replication.
In addition to deregulation of cell cycle checkpoints, HPV oncoproteins have also evolved mechanisms to evade replicative senescence caused by telomere shortening (5, 6) . Human telomeres form the chromosome ends and consist of 10 to 15 kb of tandem repeats with the hexameric sequence TTAGGG. Telomeres end with a 3 ¶ single strand overhang of the G-rich strand. The inability of DNA polymerase to replicate the end of the chromosomes during lagging strand synthesis results in the loss of telomeric sequences with each cell division (7) . A specialized enzyme, telomerase, adds telomeric repeats to the 3 ¶ overhang by using an integral RNA component as a template to prevent telomere erosion. Telomerase activity can be detected in some proliferating cells and in male germ cells, but most nondividing somatic cells do not show measurable levels of telomerase activity. In tumor cells, however, activation of telomerase is a common finding (8) .
The ability of HPV oncoproteins to evade replicative senescence has not only been linked to pRB and p53 inactivation, respectively, but also to their ability to interfere more directly with mechanisms of telomere maintenance. The HPV-16 E6 oncoprotein contributes to the extension of cellular life span and immortalization by upregulating hTERT, the catalytic subunit of telomerase (9) . Remarkably, cells expressing the HPV-16 E7 oncoprotein alone are able to maintain telomere length in an E6-independent and telomerase-independent manner (10, 11) . How the HPV-16 E7 oncoprotein promotes telomere maintenance without telomerase activation is incompletely understood, but it has been suggested that the alternative lengthening of telomere (ALT) pathway may be involved (10, 11) .
Non-telomerase-based mechanisms of telomere maintenance have initially been identified in lower organisms but subsequent studies have shown that a subset of tumors and tumor cell lines, in particular, of mesenchymal origin, rely on ALT for telomere homeostasis (12, 13) . ALT is believed to be based on homologous recombination (HR) between telomere sister chromatids, and accordingly, a number of proteins involved in the HR pathway have been identified to be required for the ALT pathway (14) . A hallmark of ALT are so-called ALT-associated promyelocytic leukemia (PML) bodies (APBs), subnuclear structures that contain telomeric DNA, telomere-binding proteins, and proteins involved in HR including RAD51 and several others (15) . The onset of ALT immortalization coincides with the appearance of APBs and their formation is hence often used as a surrogate marker for ALT activity (12) . Additional characteristics of the ALT pathway are heterogeneous telomere length and the presence of free extrachromosomal DNA circles consisting of telomeric repeat DNA (7) .
The bulk of telomeric DNA is replicated by the conventional DNA replication machinery. It has been proposed, however, that telomeres are poor replication templates and, furthermore, that replication forks tend to stall at dysfunctional telomeres (16, 17) . Stalled replication forks are known substrates of HR and processing of stalled forks has recently been suggested to be essential for normal telomere homeostasis (18) . In line with this notion are findings demonstrating telomere dysfunction in response to the inactivation of proteins required for replication fork stabilization and restart, for example, proteins of the Fanconi anemia (FA) pathway. FA cells are characterized by accelerated telomere shortening and telomere breakage, together with increased extrachromosomal telomeric DNA (19, 20) .
We have recently shown that the HPV-16 E7 oncoprotein causes an activation of the FA pathway and that FA-deficient cells exhibit increased chromosomal instability when HPV-16 E7 is expressed (21) . Whether activation of the FA pathway contributes to HPV-16 E7-associated immortalization and transformation, however, has not been explored in detail.
In the present report, we show that the HPV-16 E7 oncoprotein stimulates an enhanced formation of APBs that contain the FA D2 protein (FANCD2), which has not been previously reported to localize to APBs. Importantly, this activity of HPV-16 E7 was detected in early passage primary human keratinocytes. Mutants of HPV-16 E7 that are unable to degrade pRB or to overcome a p21 Cip1 -induced growth arrest had an impaired ability to stimulate FANCD2-containing APBs. HPV-16 E7-induced FANCD2-positive APBs contained ssDNA and formed in an ATR-dependent manner. In addition, we found FANCD2-positive APBs induced by HPV-16 E7 to colocalize with several other proteins known to respond to replication stress, most notably, BRCA2 and MUS81. We provide evidence that FANCD2 is critically involved in telomere homeostasis in ALT-positive cells because knockdown of FAND2 rapidly led to telomere dysfunction. Collectively, our results suggest that HPV-16 E7 elicits a replication stress response at telomeric DNA, which may promote the recombination-based telomere length maintenance pathway that underlies ALT. These findings may help to explain mechanistically how high-risk HPV-16 E7-expressing cells maintain telomere length in the absence of telomerase and underscore the notion that viral oncoproteins can exploit DNA damage response pathways to extend host cell life span, and hence, to support viral genome propagation (22) .
Materials and Methods
Cell culture, treatment, and transfection. U-2 OS, MCF-7, HeLa cells (American Type Culture Collection), and GM00847 fibroblasts (Coriell) were maintained as suggested by the manufacturers. Primary human keratinocytes were maintained in serum-free keratinocyte growth medium (Epilife, Cascade Biologics/Invitrogen). Cells were treated with 100 ng/mL of mitomycin C (MMC; Sigma), 1 mmol/L of hydroxyurea (Calbiochem) or distilled water for the indicated time intervals.
U-2 OS cells were stably transfected using Fugene 6 (Invitrogen) transfection reagent and 2 Ag of plasmid DNA followed by selection in DMEM supplemented with 3 mg/mL of G418 (Cellgro) Primary human foreskin keratinocytes were transduced with an LXSNbased high-risk HPV-16 E7 construct or LXSN empty vector followed by selection in G418-supplemented medium.
Immunologic methods. Preparation of cell lysates and immunofluorescence stainings were performed as previously described (23), with the exception of a prolonged permeabilization step (1% Triton X-100 in PBS for 30 min). For immunofluorescence staining of PML, cells were first treated with a soluble protein extraction buffer (10 mmol/L PIPES, 300 mmol/L sucrose, 3 mmol/L MgCl 2 , 20 mmol/L NaCl, 0.5% Triton X-100; pH 6.8) as previously described (24) . Cells were then incubated with primary antibodies overnight at 4jC and again for at least another 2 h at 37jC in a humidified chamber. Cells were then washed with PBS and incubated with FITC-or rhodamine red-conjugated antimouse or antirabbit secondary antibodies (Jackson Immunoresearch) for at least 2 h at 37jC, washed with PBS and counterstained with 4 ¶,6 ¶-diamidino-2-phenylinodole (DAPI; Vector Laboratories).
Primary antibodies used for immunoblotting and immunofluorescence were 53BP1 (Novus Biologicals), actin (Sigma), ATM (Genetex), phosphorylated ATM at serine 1981 (Novus Biologicals), ATR (Genetex), BLM (Bethyl), BRCA2 (Calbiochem), 5 ¶-bromo-2 ¶ deoxyuridine (BrdUrd; Roche Diagnostics), FANCD2 (Genetex), HA (Santa Cruz Biotechnology), HPV-16 E7 (Santa Cruz Biotechnology), g-H2AX (Trevigen), MRE11 (Genetex), PML (Santa Cruz Biotechnology), RAD51 (Genetex), RPA32 (Lab Vision), and TRF2 (Imgenex).
Detection of ssDNA. To detect ssDNA, cells were labeled with 10 Amol/L of BrdUrd (Roche Diagnostics) for 24 h in DMEM. All cells were washed once with fresh DMEM and processed immediately for BrdUrd immunofluorescence as described above without any prior denaturation step. Cells were then incubated with a mouse monoclonal BrdUrd antibody (Roche Diagnostics), followed by incubation with a rhodamine redconjugated antimouse secondary antibody (Jackson Immunoresearch). This technique utilizes the fact that the incorporated base analogue can only be recognized by the monoclonal BrdUrd antibody when the DNA is in a single-stranded form (25) .
Small interfering RNA and small hairpin RNA. Synthetic RNA duplexes were used to reduce ATM or ATR expression. Oligonucleotides targeting ATM, ATR, or control were obtained commercially (siGENOME SMARTpool; Dharmacon) and used according to the manufacturer's protocol.
Small hairpin RNA (shRNA) constructs against FANCD2 or control (GFP) were obtained commercially (HuSH, Origene). U-2 OS cells were transiently transfected using nucleofection (Amaxa) with either pooled shFANCD2 constructs (2 Ag of each of the four constructs provided) or 2 Ag of shGFP in addition to 6 Ag of herring sperm. Cells were processed for further analysis at 72 h after transfection.
Telomere fluorescence in situ hybridization. Telomere fluorescence in situ hybridization (FISH) was performed using a Cy3-conjugated telomere PNA probe (Telomere PNA FISH kit/Cy3; Dako) according to the manufacturer's protocol.
Statistical methods. Student's two-tailed t test for independent samples was used to assess statistical significance.
Results
Overexpression of the HPV-16 E7 oncoprotein stimulates the formation of FANCD2-containing nuclear foci that show key characteristics of APBs. We have previously shown that the HPV-16 E7 oncoprotein triggers an activation of the FA pathway (21) . Besides DNA damage-associated FANCD2 nuclear foci, we noted that a number of cells contained unusually large foci with a more complex architecture, in particular, a ring-shaped appearance (21) . To test whether such foci could be induced by HPV oncoproteins, we performed an immunofluorescence microscopic analysis of FANCD2 foci in asynchronously growing U-2 OS cells engineered to stably express HPV-16 E7, HPV-16 E6, or empty vector plasmids (kindly provided by K. Münger, Channing Laboratory, Brigham and Women's Hospital, Boston, MA). A proportion of cells in HPV-16 E7-expressing populations displayed unusually large FANCD2 foci that showed a highly distinctive ringshaped appearance (Fig. 1A) . Such ring-or donut-shaped foci containing PML and telomeric DNA have previously been recognized as hallmarks of ALT and are referred to as APBs (15) . A statistically significant 2-fold increase of cells that contained large ring-shaped FANCD2 foci was detected-from 7.2% in empty vector controls to 14.3% in HPV-16 E7-expressing cells (P V 0.005; Fig. 1B ). In contrast, stable expression of HPV-16 E6 did not result in an increase of cells with such foci as compared with controls (6.3%; P > 0.05; Fig. 1B ). Stable expression of low-risk HPV-6 E7 (kindly provided by Denise Galloway) in U-2 OS cells also did not induce a significant increase of ring-shaped FANCD2 foci when compared with controls (Fig. 1C) . When we stably expressed HPV-16 E7 in HeLa or MCF-7 cells, which use telomerase to maintain telomere length (15) , and not ALT such as U-2 OS cells, no induction of ring-shaped FANCD2 was detected (data not shown).
To further explore the role of HPV-16 E7 in the formation of ringshaped FANCD2 foci, we performed a mutational analysis (Fig. 1D) . We found that mutant HPV-16 E7 that is unable to degrade pRB and the other pocket proteins (E7D21-24; kindly provided by Karl Münger) was also unable to stimulate an increase of ring-shaped FANCD2 foci. COOH-terminal mutants of HPV-16 E7 that degrade pRB, but are deficient in overcoming a p21
Cip1 -mediated growth arrest (E7CVQ68-70AAA and E7 D79-83; kindly provided by Denise Galloway), were only able to trigger a minor increase of such foci that was below what is found in cells expressing wild-type HPV-16 E7. These results suggest that both pRB-dependent and pRB-independent functions of HPV-16 E7 contribute to the formation of ring-shaped FANCD2-containing foci.
The ring-shaped appearance of the FANCD2 foci, together with the fact that they formed in ALT-positive but not in ALT-negative cell lines (26, 27) , was highly suggestive of APBs (13, 15) . APBs have been reported to contain PML, telomeric DNA, telomere-binding proteins, as well as various DNA damage response proteins. Because the present report is the first to suggest that FANCD2 localizes to APBs, we next sought to further corroborate this finding.
A coimmunofluorescence analysis for FANCD2, PML, and the telomere-binding protein TRF2 in HPV-16 E7-expressing and control cells was performed. We found that the majority of ringshaped FANCD2 foci in HPV-16 E7-expressing cells colocalize with PML (72.5%; Fig. 2A, top) . In addition to PML, ring-shaped FANCD2 foci also colocalized with TRF2 in HPV-16 E7-expressing cells (80.4%; Fig. 2A, middle) . Furthermore, by combining in situ hybridization for telomeric DNA using a Cy3-conjugated probe and immunofluorescence for FANCD2, we show that the vast majority of ring-shaped FANCD2 foci contain telomeric DNA sequences (94.1%; Fig. 2A, bottom) . In the majority of cells, we detected relatively few ring-shaped FANCD2 foci per nucleus, which is another characteristic of APBs in ALT cells (15) . FANCD2 was also found to colocalize with PML and TRF2 in another ALT cell line, GM00847 (data not shown). Taken together, these findings provide additional support for the notion that FANCD2 is a novel component of APBs and that overexpression of HPV-16 E7 stimulates an increased formation of FANCD2-containing APBs.
HPV-16 E7-induced FANCD2-containing APBs colocalize with ssDNA and proteins involved in the stabilization and restart of stalled DNA replication forks. To substantiate a possible link between FANCD2-containing APBs and replication stress, we determined the presence of ssDNA in these foci using a modified BrdUrd staining protocol (Fig. 2B) . APBs containing ssDNA were significantly increased in HPV-16 E7-expressing cells (1.6-fold; 21.5%) when compared with control cells (13.2%, P < 0.001, Fig. 2C ). These results underscore that the increase of FANCD2-containing APBs in HPV-16 E7-expressing cells involves DNA replication stress.
A series of coimmunofluorescence experiments were performed to determine the presence of additional markers of APBs in HPV-16 E7-expressing cells (Fig. 3) . Among the proteins that have previously been reported to localize to APBs are RPA32, BLM, RAD51, and MRE11 (12) . As expected, all of these proteins were found in HPV-16 E7-induced FANCD2-containing APBs (Fig. 3) . The percentages of colocalization of ring-shaped FANCD2 foci with the respective proteins were 100% for RPA32, 86% for BLM, 27.3% for RAD51, and 86.6% for MRE11 in HPV-16 E7-expressing cells.
Besides the identification of FANCD2 itself as a novel APB component, we found that BRCA2 and MUS81 colocalize with FANCD2 in these foci (Fig. 3) . Both proteins, to the best of our knowledge, have not been previously reported as APB components. BRCA2 is also known as FANCD1 and was found to localize to 33% of FANCD2-positive APBs in HPV-16 E7-expressing cells. FANCD2 interacts with BRCA2 and promotes its loading onto chromatin in which BRCA2 has been implicated in the stabilization of stalled replication forks (28) . MUS81, which was found in 38.4% of FANCD2-positive APBs in HPV-16 E7-expressing cells, has endonuclease activity and has been implicated in resolving Holliday junctions that arise following stalling of DNA replication forks (29) . MUS81 might also be involved in forming DNA double-strand breaks at stalled replication forks (30) . In line with this notion, we detected g-H2AX and serine 1981-phosphorylated ATM in a fraction of FANCD2-positive APBs (data not shown). Taken together, the finding that BRCA2/FANCD1 and MUS81 colocalize to FANCD2-positive APBs is suggestive of the role of stalled replication forks as a trigger of ALT activity in HPV-16 E7-expressing cells.
Replication stress-inducing agents stimulate APB formation. We next tested whether drugs that induce the stalling of replication forks can mimic the phenotype observed in HPV-16 E7-transfected U-2 OS cells. U-2 OS cells treated for 24 hours with 100 ng/mL of MMC, a DNA cross-linking agent that leads to a robust activation of the FA pathway, displayed a significant 2.3-fold increase of FANCD2-positive APBs (23.2%, P < 0.001) in comparison with controls (10.1%; Fig. 4A ). Treatment with MMC, however, may also lead to DNA double-strand breaks. To verify that the formation of FANCD2-containing APBs is triggered by stalled replication, we treated cells with hydroxyurea, a ribonucleotide reductase inhibitor that induces an arrest in early S phase and replication fork block by depleting the intracellular deoxynucleotide pools. We observed a significant 2.3-fold increase of FANCD2-positive APB foci in U-2 OS cells that had been treated with 1 mmol/L of hydroxyurea for 72 hours, from 15.3% in controls to 34.8% (P V 0.005; Fig. 4B ). These results support the notion that replication stress can lead to an increased formation of FANCD2-positive APBs.
HPV-16 E7-induced increase of FANCD2-containing APBs requires the ATR but not the ATM kinase. In order to further corroborate that the induction of FANCD2-containing APBs by HPV-16 E7 is part of a replication stress response, we determined whether their formation is dependent on ATR. Activation of ATR is an integral part of the cellular response to DNA replication stress and has been shown to function upstream of the FA pathway (31) . HPV-16 E7-expressing U-2 OS cells were transiently transfected with small interfering RNA (siRNA) duplexes targeting ATR in comparison to ATM or control siRNAs. Immunoblot analyses showed a significant knockdown of protein expression at 72 hours (Fig. 4C) . Immunofluorescence microscopy for FANCD2-positive APBs in HPV-16 E7-expressing cells revealed a significant 2.8-fold (P V 0.0005) decrease of these foci in ATR-depleted cells (4.8%) when compared with controls at 72 hours (13.7%; Fig. 4D and E). Depletion of ATM had no effect on the frequency of FANCD2 foci (15%) in HPV-16 E7-expressing cells. Notably, previous results have shown that conventional APB formation in U-2 OS cells does not require ATM or ATR (32) . Our findings hence suggest that the HPV-16 E7-induced formation of APBs in an ATR-dependent manner is part of a replication stress response.
Knockdown of FANCD2 in ALT cells causes telomere dysfunction. To directly test the role of FANCD2 in telomere homeostasis in cells that rely on ALT for telomere maintenance, we depleted FANCD2 in U-2 OS cells using shRNA constructs (Fig. 5A) . Previous reports have shown that critical telomere shortening leads to the recruitment of DNA damage proteins to chromosome ends, including 53BP1 (also referred to as telomere dysfunction-induced foci; ref. 7) . We found that knockdown of FANCD2 rapidly caused telomere dysfunction in U-2 OS cells, as evidenced by an increased proportion of cells with 53BP1 foci at telomeres (Fig. 5B) . Quantification of cells with more than five telomere-associated 53BP1 foci revealed a statistically significant 6.9-fold increase from 2.6% in controls to 17.9% in FANCD2-depleted cells (P V 0.0001; Fig. 5C ). These results underscore that FANCD2 plays a role in maintaining telomere integrity in cells that use ALT for telomere maintenance.
HPV-16 E7 stimulates APB formation in early passage primary human keratinocytes. Lastly, we sought to address the question of whether HPV-16 E7 can stimulate APB formation in non-immortalized primary human keratinocytes. Starting at passage 2, primary human keratinocytes transduced with either empty vector (LXSN) or HPV-16 E7 were analyzed by coimmunofluorescence microscopy for FANCD2 and TRF2 to identify FANCD2-positive APBs (Fig. 6A ). APBs were absent in control keratinocytes up to passage 9, at which point, the cells ceased to proliferate (Fig. 6B) . In contrast, we detected a gradual increase of cells with APBs in HPV-16 E7-expressing keratinocytes starting with 0.05% at passages 2 and 5 and reaching 1.05% at passage 9 (P V 0.05 when compared with controls; Fig. 6B ). Later passages of HPV-16 E7-expressing keratinocyte populations showed a fluctuation of the proportion of cells with FANCD2-positive APBs ranging between 0.2% and 1.7% (at passage 18). These results underscore that HPV-16 E7 can stimulate the formation of APBs in early passage primary human keratinocytes, and furthermore, that APB-positive cells may have a growth advantage.
Discussion
HPV-16 E7-expressing keratinocytes have previously been shown to be able to maintain telomeres independently of telomerase (10, 11) . The precise molecular basis of this finding remains unclear, but it has been suggested that the ALT pathway is involved (10, 11) .
In the present study, we show that the HPV-16 E7 oncoprotein increases the formation of APBs that contain FANCD2, a key protein of the FA pathway that is activated by genotoxic stress, in particular, stalled replication forks (33) . This is the first report showing that FANCD2 is present in APBs and we also identified BRCA2/FANCD1 and MUS81 as novel components of FANCD2-containing APBs. These results lend support to the notion that aberrant replication structures contribute to APB formation in HPV-16 E7-expressing cells. In line with these results, FANCD2-containing APBs were increased in cells treated with replication stress-inducing agents. Furthermore, depletion of ATR was found to reduce FANCD2-containing APBs in HPV-16 E7-expressing cell populations. A previous study failed to detect enhanced APB formation following hydroxyurea treatment (34), which we explain primarily by cell type-specific differences between the U-2 OS cells used here and the primary cells used by Fasching and coworkers (34) .
Importantly, we show that the knockdown of FANCD2 rapidly leads to telomere dysfunction in ALT cells. Previous reports have shown that FANCD2 has a protective role in telomere homeostasis. FANCD2 not only localizes to meiotic telomeres (35) but cells from patients with a defective FA pathway frequently have shortened telomeres and show increased breakage at telomeric sequences as well as increased extrachromosomal telomeric DNA. Although FANCG-deficient mice have normal telomere length (36) , it is noteworthy that FANCD2-deficient mice develop epithelial cancers, which are often associated with telomere erosion (37) . Whether the telomere dysfunction detected in ALT cells following depletion of FANCD2 (Fig. 5) is a reflection of a general role of FANCD2 in telomere homeostasis in non-ALT cells remains to be determined. ALT is thought to be based on inappropriate HR at telomeres and the FA pathway has been implicated in HR-mediated DNA repair (33) . It is hence possible that FANCD2-associated activities during deregulated HR repair are the source of extrachromosomal telomeric circles or telomeric sister chromatid exchanges, both hallmarks of ALT (7).
Our results suggest that the ability of HPV-16 E7 to inactivate pRB and pRB family members, together with its ability to overcome a p21
Cip1 -mediated growth arrest (38) (39) (40) , are important for APB formation. These functions contribute to the deregulation of cyclin/ cyclin-dependent kinase activity, which has previously been shown to cause increased replication fork stalling (41) . Such events are very likely to particularly affect telomeric repeat DNA (16, 17) and would hence render telomeres prone to DNA recombination because stalled forks are preferred substrates for HR. This idea is supported by the finding that cells deficient of pRB and the related pocket proteins exhibit a telomere phenotype suggestive of ALT (42) .
A previous study has shown that DNA methyltransferases (DNMT) play a role in telomere length maintenance and that DNMT-deficient cells undergo increased telomeric recombination and enhanced APB formation (43) . Although HPV-16 E7 has been shown to interact with DNMT1, it up-regulates DNMT's activity (44) and this interaction is hence unlikely to contribute to the increase in APB formation.
HPV-16 E7 and other early proteins (E1, E2, and E6), as well as late proteins (E1^E4, and L2) and low-risk HPV proteins, have all been found to colocalize and/or interact with PML or PMLcontaining oncogenic domains (45) (46) (47) . However, a recent study showed that viral E2-dependent transcription and viral replication do not require PML (45) . This study by Nakahara and Lambert (45) also found that it was not the expression of E6 and E7 but rather the presence of extrachromosomally replicating viral DNA that was responsible for the enhanced formation of PML-positive foci that was observed. We believe that the results shown here do not disagree with these findings because PML has been found to localize to different subsets of nuclear foci.
Although we have not tested whether direct interactions between HPV-16 E7 and PML contribute to the enhanced APB formation, several lines of evidence suggest that this mechanism is unlikely to play a role. In previous studies, the interaction of HPV E7 with PML was not limited to high-risk HPV E7 but also occurred with low-risk HPV-6 E7, and both proteins were found to equally abrogate PML IV-induced senescence (47) . In contrast, our results show a clear difference between low-risk and high-risk HPV E7 with respect to induction of FANCD2-positive APBs. The finding that wild-type HPV-16 E7 and mutant HPV-16 E7 C24G showed similar affinities to PML (47) but differed significantly in their ability to induce APBs (our results; data not shown) led us to conclude that direct HPV-16 E7-PML interactions may not play a major role in APB formation. In addition, ectopically expressed HPV-16 E7 was not found to colocalize with PML in U-2 OS cells (48) .
Although most advanced cervical lesions and cell lines use telomerase for telomere maintenance, some early cervical neoplasms lack detectable telomerase expression and show significant telomere attrition (49) . How a minimum telomere length that is necessary to avoid cell death or senescence is maintained in these lesions, which can persist for many years, remains unknown. Our finding that HPV-16 E7 can stimulate APBs in a small but significant proportion of non-immortalized primary human keratinocytes suggests that ALT may contribute to telomere maintenance in certain subpopulations of cells. Remarkably, control keratinocytes, which stopped dividing at passage 9, never showed any APBs. Clearly, telomerase is more efficient in maintaining telomere length than ALT, and clonal evolution will ultimately lead to the predominance of cells with sufficient telomerase activity as evidenced by the high frequency of telomerase expression in advanced cervical lesions and carcinomas (49, 50) . Nonetheless, the correlation between APB formation and sustained proliferation might suggest that APB-positive cells may be endowed with a growth advantage at early stages of immortalization.
Many ALT cell lines have been generated using SV40 to immortalize cells (12) . The SV40-encoded large T antigen shares key functions with HPV-16 E7, including the ability to inactivate pRB. An intriguing possibility, based on previous studies and results shown here, is that the presence of certain viral oncogenes such as SV40 large T antigen or HPV-16 E7 promotes the ALT pathway by provoking increased replication stress at telomeric DNA. The question of whether replication stress induced by the HPV-16 E7 oncoprotein is sufficient to promote ALT or whether the HPV-16 E7 oncoprotein directly targets regulators of ALT/HR repair awaits further clarification.
In conclusion, the results presented here suggest a novel link between DNA replication stress, FANCD2, and ALT in HPV-16 E7-expressing cells. These findings highlight the exploitation of host cell DNA damage responses by a viral oncoprotein to circumvent antiproliferative barriers in infected host cells (22) . Our results suggest a model in which HPV-16 E7-induced genotoxic stress leads to an activation of the FA pathway (21) , which, if it occurs at telomeres, might be used by the virus to promote ALT, extension of host cell life span, and ultimately, immortalization.
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